Single Nucleotide Polymorphism-based Identification of Bacterial Artificial Chromosome-mediated Homologous Recombination

• Published in: Frontiers in bioscience (Landmark. Print) Vol. 29; no. 8; p. 280
• Main Author: Chung, Sun-Ku
• Format: Journal Article
• Language: English
• Published: Singapore IMR Press 15.08.2024
• Subjects: bacterial artificial chromosome; Chromosomes, Artificial, Bacterial - genetics; Homologous Recombination; human pluripotent stem cell; Humans; Polymorphism, Restriction Fragment Length; Polymorphism, Single Nucleotide; restriction fragment length polymorphism; single nucleotide polymorphism; single-stranded conformational polymorphism; bacterial artificial chromosome; restriction fragment length polymorphism; single-stranded conformational polymorphism; homologous recombination; single nucleotide polymorphism; human pluripotent stem cell
• ISSN: 2768-6698; 2768-6701; 2768-6698
• DOI: 10.31083/j.fbl2908280

Bacterial Artificial chromosome (BAC) recombineering is a powerful genetic manipulation tool for the efficient development of recombinant genetic resources. Long homology arms of more than 150 kb composed of BAC constructs not only substantially enhance genetic recombination events, but also provide a variety of single nucleotide polymorphisms (SNPs) that are useful markers for accurately docking BAC constructs at target sites. Even if the BAC construct is homologous to the sequences of the target region, different variations may be distributed between various SNPs within the region and those within the BAC construct. Once the BAC construct carrying these variations was precisely replaced in the target region, the SNP profiles within the target genomic locus were directly replaced with those in the BAC. This alteration in SNP profiles ensured that the BAC construct accurately targeted the designated site. In this study, we introduced restriction fragment length polymorphism or single-strand conformation polymorphism analyses to validate and evaluate BAC recombination based on changes in SNP patterns. These methods provide a simple and economical solution to validation steps that can be cumbersome with large homologous sequences, facilitating access to the production of therapeutic resources or disease models based on BAC-mediated homologous recombination.